CLINICAL_TRIALS trial_result · 2025-05-15

Clinical Trial Update: CVT-ISR First in Human Trial for Coronary In-Stent Restenosis [NA]

Abbott Medical Devices completed a first-in-human trial of CVT-ISR for coronary in-stent restenosis, and trial results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Abbott Medical Devices | Conditions: In-stent Restenosis | NA | Status: COMPLETED | Results posted: 2025-05-15